MEMPHIS, Tenn.--(BUSINESS WIRE)--Medtronic, Inc. (NYSE: MDT), today announced the distribution of NANOSTIM™ Synthetic Bone Paste for use in surgical procedures in the European Union and other markets outside the United States. This nanohydroxyapatite-based bone graft substitute provides a supporting structure for new bone formation, aiding bone healing in places where voids or gaps exists in the bone. NANOSTIM Synthetic Bone Paste can be filled into defects regardless of their shape and stays in place keeping close contact to the surrounding bone.
